Healthpoint, DFB To Pay $48M To End FCA Drug Suit
Healthpoint Ltd. and DFB Pharmaceuticals Inc. will pay $48 million as part of a settlement agreement that ended allegations that Healthpoint submitted false claims to Medicare and Medicaid for an unapproved...To view the full article, register now.
Already a subscriber? Click here to view full article